A main objective of the PCM program is to to enhance the local machinery for early clinical trials and to optimize the collaboration with Cancer Core Europe. In this effort the PCM program facilitates the initiation and management of PCM profiled clinical trials.
Position paper by PCM Program steering group members Eskil Degsell and Mats Brommels on the need for a change in perspective in the collaboration between patient, relatives and Health care providers.
Datum: February 5, 2024
Plats: IRCCS - Istituto Nazionale dei Tumori, Milano
Information: Cancer Core Europe’s Annual Meeting 2024
Datum: January 31, 2024
Plats: Life City, Solnavägen 3H, Solna
Information: Panel: The future of health: How can patient reported data lead to improved treatments?
